GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $584,000 | +28.1% | 13,424 | +28.2% | 0.02% | -4.0% |
| Q1 2022 | $456,000 | -4.6% | 10,475 | -3.3% | 0.02% | 0.0% |
| Q4 2021 | $478,000 | +68.9% | 10,827 | +46.7% | 0.02% | +38.9% |
| Q3 2021 | $283,000 | -3.7% | 7,382 | 0.0% | 0.02% | -5.3% |
| Q2 2021 | $294,000 | +42.0% | 7,382 | +27.1% | 0.02% | +35.7% |
| Q1 2021 | $207,000 | +1.0% | 5,810 | +4.5% | 0.01% | -6.7% |
| Q4 2020 | $205,000 | -39.9% | 5,560 | -38.6% | 0.02% | -46.4% |
| Q3 2020 | $341,000 | -7.8% | 9,060 | 0.0% | 0.03% | -15.2% |
| Q2 2020 | $370,000 | +11.4% | 9,060 | +3.3% | 0.03% | -5.7% |
| Q1 2020 | $332,000 | -15.9% | 8,770 | +4.3% | 0.04% | +2.9% |
| Q4 2019 | $395,000 | +10.0% | 8,410 | 0.0% | 0.03% | +3.0% |
| Q3 2019 | $359,000 | -19.9% | 8,410 | -24.8% | 0.03% | -21.4% |
| Q2 2019 | $448,000 | -4.3% | 11,184 | 0.0% | 0.04% | -8.7% |
| Q1 2019 | $468,000 | +9.9% | 11,184 | +0.2% | 0.05% | -2.1% |
| Q4 2018 | $426,000 | -4.9% | 11,157 | 0.0% | 0.05% | +2.2% |
| Q3 2018 | $448,000 | -0.4% | 11,157 | 0.0% | 0.05% | -8.0% |
| Q2 2018 | $450,000 | +3.2% | 11,157 | 0.0% | 0.05% | +2.0% |
| Q1 2018 | $436,000 | +74.4% | 11,157 | +57.8% | 0.05% | +81.5% |
| Q4 2017 | $250,000 | -25.1% | 7,069 | -14.1% | 0.03% | -30.8% |
| Q3 2017 | $334,000 | -6.4% | 8,229 | -0.7% | 0.04% | -9.3% |
| Q2 2017 | $357,000 | +1.7% | 8,285 | -0.4% | 0.04% | -2.3% |
| Q1 2017 | $351,000 | +9.3% | 8,322 | 0.0% | 0.04% | +4.8% |
| Q4 2016 | $321,000 | -33.8% | 8,322 | -26.0% | 0.04% | -36.4% |
| Q3 2016 | $485,000 | +3.2% | 11,250 | +3.6% | 0.07% | +6.5% |
| Q2 2016 | $470,000 | +5.9% | 10,855 | -0.8% | 0.06% | -1.6% |
| Q1 2016 | $444,000 | -13.3% | 10,945 | -13.8% | 0.06% | -11.3% |
| Q4 2015 | $512,000 | +5.3% | 12,696 | +0.3% | 0.07% | -4.1% |
| Q3 2015 | $486,000 | -2.8% | 12,660 | +5.5% | 0.07% | +4.2% |
| Q2 2015 | $500,000 | +4.8% | 12,004 | +16.1% | 0.07% | +4.4% |
| Q1 2015 | $477,000 | +15.5% | 10,337 | +6.9% | 0.07% | +15.3% |
| Q4 2014 | $413,000 | +21.5% | 9,669 | +30.6% | 0.06% | +13.5% |
| Q3 2014 | $340,000 | -12.4% | 7,401 | +1.9% | 0.05% | -5.5% |
| Q2 2014 | $388,000 | 0.0% | 7,263 | 0.0% | 0.06% | -1.8% |
| Q1 2014 | $388,000 | -16.4% | 7,263 | -16.4% | 0.06% | -18.8% |
| Q4 2013 | $464,000 | +7.7% | 8,688 | +1.2% | 0.07% | 0.0% |
| Q3 2013 | $431,000 | +4.1% | 8,588 | +3.7% | 0.07% | +50.0% |
| Q2 2013 | $414,000 | – | 8,285 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |